insomina
Conditions
Interventions
insomnia group:Zaleplon Capsules 10mg
Sponsors
ZhongDa Hospital, School of Medicine, Southeast University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) aged 18 to 65 years old; (2) insomniacs with difficulty falling asleep (sleep onset latency =30min on at least 3 days per week); (3) non-organic insomnia according to ICD-10 criteria; (4) Informed consent was obtained from patients or their legal guardians.
Exclusion criteria
Exclusion criteria: (1) 3 or more days a week, easy to wake up at night or early awakening; (2) the baseline GAD - 7 or 15 or PHQ - September 20 or more; (3) merging other mental disease or secondary insomnia patients, such as in the use of certain drugs or in organic encephalopathy, serious body disease on the basis of the occurrence of insomnia disorders; (4) there is obstructive sleep apnea, restless leg syndrome or rem sleep behavior disorder, excessive sleepiness barriers and any may affect the results of the study of disease states; (5) history of alcohol and drug dependence and serious diseases such as malignant tumors; (6) patients with the experience of using sedatives and hypnotics to treat insomnia in the past two weeks; (7) pregnant and lactating women; (8) Allergy to any component of Zaleplon capsule or contraindication to its use according to the instructions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective degree of sleep disorders;Daytime emotions;Subjective fatigue level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety symptoms;Depressive symptoms; | — |
Countries
China
Contacts
Public ContactYuan Yonggui
ZhongDa Hospital, School of Medicine, Southeast University
Outcome results
None listed